# ANHYDROUS DEXTROSE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid7022910
Categories: beauty, cleaning, food, industrial, pharma
Functions: Binder, Flavouring and nutrient, Fragrance, Humectant, Pharmaceutical, Processing aids not otherwise specified, brewing, crystal se, crystal setting, crystal setting time, drying additive, wine-making
Identifier: DTXSID7022910

> ANHYDROUS DEXTROSE is used as binder / flavouring and nutrient. EPA CPDat observed this chemical in 161 composition records across product categories including Construction and building materials, Laboratory supplies, Food and drug. Assessed from 20 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 161 composition records across product categories including Construction and building materials, Laboratory supplies, Food and drug.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 161 composition records across product categories including Construction and building materials, Laboratory supplies, Food and drug. EPA CPDat classifies this chemical for functional uses including Humectant, Flavouring and nutrient, Pharmaceutical.
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 300 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 3.9 %w/v
- US: inactive ingredient database — Route: INTRASPINAL; Dosage form: INJECTION; Potency: 8.25 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 36000 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 3.9 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 5 %w/v
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 36 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 40 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 16878 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER; Potency: 0.5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 17406 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 1592 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 30 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 7.5 %w/v
- US: marketed drug occurrence — FDA NDC lists this ingredient in 8 active drug products and 8 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as concept.

_Assessed by Greenveil._